Stay updated with breaking news from Area Under. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery...
Eupraxia Pharmaceuticals Inc. announced positive results from its Phase 2b clinical trial of EP-104IAR for pain associated with knee osteoarthritis ("OA"). EP-104IAR met its primary endpoint with a clinically meaningful and statistically signifi...
Lexaria's Hormone Study Shows Significant Enhancement in Oral Estradiol ...
900% and 2,000% improvements in peak bloodstream delivery using DehydraTECHKELOWNA, BC / ACCESSWIRE / May 18, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a
/PRNewswire/ -- New findings demonstrate important progress in the development of novel diagnostics for immunotherapy among other important cancer therapies,...